Similarly, cell lines with KRAS G12C had a significant lower mean LN(IC50) in the cancer-type-specific setting, encompassing LIHC, LUAD, LUSC, and pancreatic adenocarcinoma (PAAD). This evidence concerns the gene KRAS and pancreatic adenocarcinoma.